Novartis hopes to commercialise "smart lens" within 5 years
ZURICH (Reuters) - Novartis (NOVN.VX) expects the "smart lens" technology it has licensed from Google (GOOGL.O) will take several years to develop, but hopes to have a product ready for market in about five years, the drugmaker's chief executive said on Tuesday.
"This isn't going to happen overnight because it's a breakthrough technology. It's not months, we're probably talking about years. We would hope to be able to commercialise within about five years," Joe Jimenez told Reuters in an interview.
Novartis said earlier on Tuesday it had struck an agreement with Google (GOOGL.O) to develop "smart lens" technology for medical use in the eye.
(Reporting by Caroline Copley and Paul Arnold.)
- Tweet this
- Share this
- Digg this
Trending On Reuters
Ride service Uber, which is trying to enhance its image after several controversies, on Friday released the findings of a report on its handling of passenger data and said it would act on all the report's recommendations for improvements. Full Article